What changed on the page
Added news item: “Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026.”
Source: Autobound Signal API · 95 signals tracked for Merck · updated
Get Merck's live signals in Claude or ChatGPT, or by API
What changed at Merck this week? Use Autobound signals for merck.com.What changed on the page
Added news item: “Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026.”
What this signalsWebsite changes often show new positioning, products or customers.
website-intelligenceproductExpansionGet every website changes signal for Merck and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Merck this week?”
The Signal API returns website changes signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full website-intelligence record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/16973eab-6301-5c8c-8426-20fbe2ffadb5 returns this record as JSON. POST /v1/companies/enrich returns every signal for merck.com.
{
"signal_id": "16973eab-6301-5c8c-8426-20fbe2ffadb5",
"signal_type": "website-intelligence",
"signal_subtype": "productExpansion",
"detected_at": "2026-10-19T00:00:00+00:00",
"company": {
"name": "Merck",
"domain": "merck.com"
},
"data": {
"summary": "Merck showcased first-time pivotal Phase 3 oncology results from its existing portfolio at ESMO 2026.",
"evidence": "Added news item: “Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026.”",
"relevance": 0.81,
"source_url": "https://www.merck.com/investor-relations/",
"impact_rationale": "First-time pivotal oncology results provide evidence of clinical development and may support future Phase 3 programs, investor confidence, and portfolio expansion."
}
}
curl https://signals.autobound.ai/v1/signals/16973eab-6301-5c8c-8426-20fbe2ffadb5 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"merck.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.